PickleJar Holdings, Inc. acquired NewRegen, Inc. in a reverse merger transaction.
November 26, 2023
Share
PickleJar Holdings, Inc. acquired NewRegen, Inc. (OTCPK:NREG) in a reverse merger transaction on November 25, 2023. The entity will be renamed PickleJar Entertainment Group and trade on the OTC stock exchange under the ticker ?NREG? until a new ticker symbol and name is approved by FINRA. The Company will be operated by PickleJar?s management team and be headquartered in Houston, TX. Four of the PickleJar?s board members will continue to serve with another to be selected by the PickleJar board. As part of this transaction, Everett Dickson is to resign from his position as an officer and director of NewRegen on November 25, 2023. The transaction, which has been unanimously approved by PickleJar?s Board of Directors, was finalized on November 25, 2023.
PickleJar Holdings, Inc. completed the acqusition of NewRegen, Inc. (OTCPK:NREG) in a reverse merger transaction on November 25, 2023.
Newregen, Inc. provides anti-aging and regenerative medical treatments. It operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. It is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. It offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. It also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.
NEWREGEN, INC. 
